- Dermopartners skincare contract manufacturing – Sesderma Group.
- More than 25 years’ experience.
- Research, development and manufacture of innovative cosmeceuticals (GMP´s and ISO).
- R+D+i department.
- Dermocosmetics products for home use, esthetician and professional dermatologist.
- We work in partnership with our customers, developing customized solutions for their specific market requirements and target groups including home use, physicians, aestheticians and professional dermatologists.
- We develop and manufacture final products with an added value, thanks to our NANOTECH TECHNOLOGY, based on the use of liposomal active ingredients within our formulations.
We offer expert advice and practical customized solutions at every point along the value chain.
Bulk, semi–finished & finished products (flexibility: small and large runs)
Sachets and small tubes (5 ml)
Filling and packaging
In the case of customers own bulk
Development & Stability testing
Of taylor made formulations
Stability testing on approved products
Liposomes in bulk, development of new liposomes
CPNP registration (Europe) and regulatory support in case of registration in other countries
Layout service and design
Medical and technical training-workshops
We work close to our customers´ needs approaching each project based on a structured multidisciplinary process.
Definition of the Concept/Idea/Indications
Development of the formulation based on customers’ requirements and our know-how
Can include different packaging options and scale up volumen orders
Manufacturing of first samples for customer evaluation
Stability testing and other possible testing
Product design on behalf of the customer. Primary & secondary packaging
Design revision and approval
Manufacturing contract signature and order processing
Manufacturing of the first industrial batch
Formulations: creams, gels, lotions, serums, facial masks, milks, oils…
Primary packaging: tubes, bottles, jars, sachets, airless containers…
Leading through Innovation
Dermocosmetics product ingredients usually have large molecular sizes, so they are unable to penetrate the skin.
SOLUTION → NANOTECH TECHNOLOGY
Nanotech Technology is the manipulation of matter on an atomic and molecular scale to produce new structures, materials and devices with nano dimensions.
Liposomes are nano-sized structures whose composition is very similar to human cells. These vesicles are able to transport active ingredients through various structures such as skin and hair and penetrate to previously unimaginable levels.
Our Liposomes are:
Pharmaceutical grade, homogeneous and with small particle size (100nm), unilamellar (single bilayer) and able to carry:
- liposoluble active ingredients (encapsulated inside the bi-layer)
- hidrosoluble active ingredients (encapsulated inside the liposome center).
Liposomes find their way into the hair root and the deepest layers of the skin. Liposomes protect unstable ingredients (such as vitamin C, which is easily oxidized) until the time of their release.
Further, the liposomes themselves, due to their composition of essential fatty acids are capable of providing benefits such as antiinflammatory and epithelizing effects.
Sesderma Laboratories and the General University Hospital of Valencia Research Foundation conducted a study to determine how liposomes penetrate through cutaneous structures such as skin and hair.
Research and development of new functionalized liposomes for the treatment of vitiligo and psoriasis
Project description: Vitiligo and psoriasis are chronic skin diseases with a prevalence of 2% and 3% worldwide, respectively. In addition, in some cases patients present an anatomical coexistence of both types of dermatological lesions. Although different studies show that the incidence of psoriasis in patients with vitiligo is not higher than in the general population, this association is not considered rare, but rather underreported in clinics.
Currently, due to the lack of knowledge and the autoimmune nature of these diseases, existing treatments do not represent sustainable solutions due to the high risk of side effects and the lack of specificity at the cellular level.
That is why Dermopartners has proposed to establish a decisive milestone in the sector, through the research and subsequent development of novel functionalized liposomes to respond to the existing limitations in the treatments of vitiligo and psoriasis.
Objective: The development of novel systems for transporting functionalized actives that ensure their effectiveness, as well as a high specificity towards the therapeutic targets responsible for the dermatological disorders caused by vitiligo and psoriasis, thereby improving current state of the art results of treatments.
Results: Milestone 1 of the project has been reached and the technology is developed on a laboratory scale.
- South Korea
We provide expert advice and practical customized solutions at every point along the value chain.
Our passion for the skin translates into a daily commitment to all our customers through their marketing channels:
- Aesthetic/Cosmetic Doctors
- Plastic Surgeons
- Beauty centers
- Owned shops & franchises
Se informa que sus datos personales recogidos mediante el formulario de contacto, serán tratados por cuenta de DERMOPARTNERS, S.L., en calidad de responsable del tratamiento, con el fin de gestionar y atender las solicitudes de información, dudas, quejas, así como conocer la opinión de los usuarios, respecto a los productos ofertados en la presente página web, y, poderle remitir información de su interés a través de comunicaciones comerciales, en virtud del consentimiento manifestado por Usted. Los datos se conservarán durante el tiempo necesario para cumplir con la finalidad para la que se recabaron. Los datos podrán ser cedidos tal y como se detalla en la Política de Privacidad. Asimismo, en cualquier momento podrá ejercer sus derechos de Acceso, Rectificación, Supresión, Portabilidad, Limitación o, en su caso, Oposición. Si quiere conocer más información la tiene disponible aquí.
El proyecto “NUEVOS PRODUCTOS COSMÉTICOS Y SANITARIOS MEDIANTE LA PRODUCCIÓN RECOMBINANTE DE PROTEÍNAS Y ANTICUERPOS PARA INMUNOAFINIDAD” liderado por DERMOPARTNERS ha recibido financiación por parte del Ministerio de Economía y Competitividad en la convocatoria de Retos Colaboración del año 2015 del Programa Estatal de Investigación Científica y Técnica y de Innovación 2013-2016.
El proyecto está cofinanciado por la Unión Europea, a través de los Fondos Europeos de Desarrollo Regional
N º expediente: RTC-2015-4374-1